Advertisement

The HPA Axis and Depressive Disorders

  • Roger F. Haskett
Part of the The Depressive Illness Series book series (DISS, volume 3)

Abstract

During the past two decades, various abnormalities of hypothalamicpituitary-adrenocortical (HPA) axis function have been described in patients with depressive illness. Abnormalities were initially observed at the most peripheral level, i.e., urinary excretion of cortisol metabolites, but the development of reliable assays for the direct measurement of circulating hormones provided the impetus for an extensive progression of studies. Although the focus of investigation has undergone period reevaluation, the phenomenon of HPA axis dysregulation continues to intrigue investigators of the biology of depression and the “stress response.”

Keywords

Depressed Patient Endogenous Depression Pituitary Peptide Chronic Corticosterone Treatment Sone Suppression Test 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Akil H, Haskett RF, Young EA, Grunhaus L, Kotun J, Weinberg V, Greden J, and Watson SJ: Multiple HPA profiles in endogenous depression: Effects of age and sex on cortisol and beta-endorphin. Biol Psychiat 1992 (in press).Google Scholar
  2. Alexopoulos GS, Young RC, Kocsis JH, Brockner N, Butler TA, Stokes PE: Dexamethasone suppression tests in geriatric depression. Biol Psychiat 1984; 19: 1567–1571.PubMedGoogle Scholar
  3. Amersterdam JD, Maislin G, Winokur A, Berwish N, Kling M, Gold P: The oCRH stimulation test before and after clinical recovery from depression. J Affect Disord 1988; 14: 213–222.CrossRefGoogle Scholar
  4. Amsterdam JD, Maislin G, Winokur A, Kling M, Gold P: Pituitary and adrenocortical responses to the ovine corticotropin releasing hormone in depressed patients and healthy volunteers. Arch Gen Psychiat 1987a; 44: 775–781.PubMedCrossRefGoogle Scholar
  5. Amsterdam JD, Marinelli DL, Arger P, Winokur A: Assessment of adrenal gland volume by computed tomography in depressed patients and healthy volunteers. Psychiat Res 1987b; 21: 189–197.CrossRefGoogle Scholar
  6. Amsterdam JD, Winokur A, Abelman E, Lucki I, Rickels K: Cosyntropin (ACTHa1–24) stimulation test in depressed patients and healthy subjects. Am J Psychiat 1983; 140: 907–909.PubMedGoogle Scholar
  7. Arana GW, Baldessarini RJ, Ornsteen M: The dexamethasone suppression test for diagnosis and prognosis in psychiatry. Arch Gen Psychiat 1985; 42: 1193–1204.PubMedCrossRefGoogle Scholar
  8. Bowie PCW, Beaini A: Normalization of the dexamethasone suppression test: A correlate of clinical improvement in primary depressives. Brit J Psychiat 1985; 147: 30–35.PubMedCrossRefGoogle Scholar
  9. Bowie PCW, Beaini AY, Bowie LJ: The prognosis of primary depressive illness: Its relationship to the dexamethasone suppression. Brit J Psychiat 1987; 150: 787–790.PubMedCrossRefGoogle Scholar
  10. Carroll BJ: The dexamethasone suppression test for melancholia. Brit J Psychiat 1982; 140: 292–304.PubMedCrossRefGoogle Scholar
  11. Carroll BJ, Curtis GC, Mendels J: Neuroendocrine regulation in depression, I: Limbic system-adrenocortical dysfunction. Arch Gen Psychiat 1976a; 33: 1039–1044.PubMedCrossRefGoogle Scholar
  12. Carroll BJ, Curtis GC, Mendels J: Neuroendocrine regulation in depression, II: Discrimination of depressed from nondepressed patients. Arch Gen Psychiat 1976b; 33: 1051–1058.PubMedCrossRefGoogle Scholar
  13. Carroll BJ, Feinberg M, Greden JF, Tarika J, Albala AA, Haskett RF, James NM, Kronfol Z, Lohn N, DeVigne JF, Young E: A specific laboratory test for the diagnosis of melancholia. Standardization, validation and clinical utility. Arch Gen Psychiat 1981; 38: 15–22.PubMedCrossRefGoogle Scholar
  14. Coryell W, Zimmerman M: HPA-axis abnormalities in psychiatrically well controls. Psychiat Res 1987; 20: 265–273.CrossRefGoogle Scholar
  15. Dallman MF, Levin N, Akana SF, Jacobson L, Shinsoki J: In vivo characterization of corticosterone feedback regulation of ACTH secretion. In: Ganong WF, Dallman MF, Roberts JL (Eds.), The Hypothalamic-Pituitary-Adrenal Axis Revisited. New York: New York Academy of Science, 1987.Google Scholar
  16. Davidson J, Lipper S, Zung WWK, Strickland R, Krishnan R, Mahorney S: Validation of four definitions of melancholia by the dexamethasone suppression test. Am J Psychiat 1984; 141: 1220–1223.PubMedGoogle Scholar
  17. DeKloet ER, Reul JMHM: Feedback action and tonic influence of corticosteroids on brain function: A concept arising from the heterogeneity of brain receptor systems. Psychoneuroendocrinology 1987; 12: 83–105.CrossRefGoogle Scholar
  18. Fang VS, Tricou BJ, Robertson A, Meltzer HY: Plasma ACTH and cortisol levels in depressed patients: Relation to dexamethasone suppression test. Life Sci 1981; 29: 931–938.PubMedCrossRefGoogle Scholar
  19. Funder JW: Adrenocorticoid receptors in the brain. Frontiers Neuroendocrinol 1986; 9: 169–189.Google Scholar
  20. Funder JW, Feldman D, Edelman IS: The roles of plasma binding and receptor specificity in the mineralocorticoid action. Endocrinology 1973; 92: 994–1004.PubMedCrossRefGoogle Scholar
  21. Gold PW, Goodwin FK, Chrousos GP: Clinical and biochemical manifestations of depression: Relation to the neurobiology of stress. New Engl J Med 1988; 319: 348–353.PubMedCrossRefGoogle Scholar
  22. Gold PW, Loriaux DL, Roy A, Kling MA, Calabrese JR, Kellner CH, Nielman LK, Post RM, Pickar D, Gallucci W, Avgerinos P, Paul S, Oldfield EH, Cutler GB, Chrousos GP: Response to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing’s disease. New Engl J Med 1986; 314: 1329–1335.PubMedCrossRefGoogle Scholar
  23. Goldberg IK: Dexamethasone suppression test as indicator of safe withdrawal of antidepressant therapy. Lancet 1980; 1: 376.PubMedCrossRefGoogle Scholar
  24. Greden JF, Albala AA, Haskett RF, James N, Goodman L, Steiner M, Carroll BJ: Normalization of dexamethasone suppression tests: A probable index of recovery among endogenous depressives. Biol Psychiat 1980; 15: 449–458.PubMedGoogle Scholar
  25. Greden JF, DeVigne JP, Albala AA, Tarika J, Buttenheim M, Eiser A, Carroll BJ: Serial dexamethasone suppression tests among rapidly cycling bipolar patients. Biol Psychiat 1982; 17: 455–462.PubMedGoogle Scholar
  26. Greden JF, Flegel P, Haskett RF, Dilsaver S, Carroll BJ, Grunhaus L, Genero N: Age effects in serial hypothalamic-pituitary-adrenal monitoring. Psychoneuroendocrinology 1986; 11: 195.PubMedCrossRefGoogle Scholar
  27. Greden JF, Gardner R, King D, Grunhaus L, Carroll BJ, Kronifol Z: Dexamethasone suppression tests in antidepressant treatment of melancholia: The process of normalization and test—retest reproducibility. Arch Gen Psychiat 1983; 40: 493–500.PubMedCrossRefGoogle Scholar
  28. Halbreich U, Asnis GM, Zumoff B, Nathan RS: The effect of age and sex on cortisol secretion in depressives and normals. Psychiat Res 1984; 13: 221–229.CrossRefGoogle Scholar
  29. Halbreich W, Asnis GM, Shindledecker R, Zumoff B, Nathan RS: Cortisol secretion in endogenous depression, II. Time-related functions. Arch Gen Psychiat 1985; 42: 909–914.PubMedCrossRefGoogle Scholar
  30. Haskett RF: Diagnostic categorization of psychiatric disturbance in Cushing’s Syndrome. Am J Psychiat 1985; 142: 911–916.PubMedGoogle Scholar
  31. Haskett RF: Psychiatric effects of corticosteroids. In: Burrows GD, Norman TR, Davies B (Eds.), Drugs in Psychiatry, Amsterdam: Elsevier, 1987, 237–245.Google Scholar
  32. Haskett RF, Young EA, Greden JF: Natural history of f3-endorphin response to dexamethasone during depression. In Annual Meeting of the Society of Biological Psychiatry. Program Abstracts, Montreal, Quebec, 1988.Google Scholar
  33. Haskett RF, Zis AP, Albala AA, Lohr NE, Carroll BJ: Comparison of early and delayed inpatient dexamethasone suppression tests. Psychiat Res 1989; 27: 161–171.CrossRefGoogle Scholar
  34. Holsboer F, Bardelehen U, Gerken A, Stalla G, Muller O: Blunted corticotropin and normal cortisol response to human corticotropin-releasing factor in depression. N Engl J Med 1984; 311: 1127.PubMedGoogle Scholar
  35. Jaeckle RS, Kathol RG, Lopez JF, Meller WH, Krummel SJ: Enhanced adrenal sensitivity to exogenous ACTHl_24 stimulation in major depression: Relationship to dexamethasone suppression test results. Arch Gen Psychiat 1987; 44: 233–240.PubMedCrossRefGoogle Scholar
  36. Kalin NH, Weiler SJ, Shelton SE: Plasma ACTH and cortisol concentrations before and after dexamethasone. Psychiat Res 1982; 7: 87–92.CrossRefGoogle Scholar
  37. Keller-Wood ME, Dallman MF: Corticosteroid inhibition of ACTH secretion. Endocr Rev 1984; 5: 1–24.PubMedCrossRefGoogle Scholar
  38. Lahti AC, Haskett RF, Murphy-Weinberg V, Young EA, Watson SJ, Akil H: Hypothalamic-pituitary-adrenal dysfunction and family subtypes of depression. In American Psychiatric Association Meeting, Program Abstract NR74. New Orleans, LA, 1991.Google Scholar
  39. Lewis DA, Pfohl B, Schlechte J, Coryell W: Influence of age on the cortisol response to dexamethasone. Psychiat Res 1984; 13: 213–220.CrossRefGoogle Scholar
  40. Linkowski P, Mendlewicz J, Leclercq R, Brasseur M, Hubain P, Goldstein J, Copinschi G, Van Cauter E: The 24-hour profile of adrenocorticotropin and cortisol in major depressive illness. J Clin Endocrinol Metab 1985; 61: 429.PubMedCrossRefGoogle Scholar
  41. Matthews J, Akil H, Greden J, Charney D, Weinberg V, Rosenbaum A, Watson SJ: Beta-endorphin/beta-lipotropin-like immunoreactivity in endogenous depression: Effect of dexamethasone. Arch Gen Psychiat 1986; 43: 374–381.PubMedCrossRefGoogle Scholar
  42. McEwen BS: Glucocorticoid-biogenic amine interactions in relation to mood and behavior. Biochem Pharmacol 1987; 36 (11): 1755–1763.PubMedCrossRefGoogle Scholar
  43. McEwen BS, DeKloet ER, Rostene WH: Adrenal steroid receptors and actions in the nervous system. Physiol Rev 1986; 66: 1121–1188.PubMedGoogle Scholar
  44. Meador-Woodruff J, Greden JF, Grunhaus L, Haskett RF: Severity of depression and hypothalamic-pituitary adrenal axis dysregulation: Identification of contributing factors. Acta Psychiat Scand 1990; 81: 364–371.PubMedCrossRefGoogle Scholar
  45. Miller KB, Nelson JC: Does the dexamethasone suppression test relate to subtypes, factors, symptoms, or severity? Arch Gen Psychiat 1987; 44: 769–774.PubMedCrossRefGoogle Scholar
  46. Mullen PE, Linsell CR, and Parker D: Influence of sleep disruption and calorie restriction on biological markers for depression. Lancet 1986; 11: 1051–1055.CrossRefGoogle Scholar
  47. Nasr SJ, Rodgers C, Pandey G, Altman EG, Gaviria FM, Davis JM: ACTH and the dexamethasone suppression test in depression. Biol Psychiat 1983; 18: 1069–1073.PubMedGoogle Scholar
  48. Nemeroff CB, Owens MJ, Bissette G, Andorn AC, Stanley M: Reduced corticotropin releasing actor finding sites in the frontal cortex of suicide victims. Arch Gen Psychiat 1988; 45: 577–579.PubMedCrossRefGoogle Scholar
  49. Nemeroff CB, Widerlov E, Bissette G, Walleus H, Karlsson I, Eklund K, Kilts CD, Loosen PT, Vale W: Elevated concentrations of CSF corticotropin-releasingfactor-like immunoreactivity in depressed patients. Science 1984; 226: 1342–1344.PubMedCrossRefGoogle Scholar
  50. Oxenkrug GF, Pomara N, McIntyre IM, Branconnier RJ, Stanley M, Gershon S: Aging and cortisol resistance to suppression by dexamethasone: A positive correlation. Psychiat Res 1983; 10: 125–130.CrossRefGoogle Scholar
  51. Peselow ED, Stanley M, Filippi AM, Barouche F, Goodnick P and Fieve RR: The predictive value of the dexamethasone suppression test. Brit J Psychiat 1989; 155: 667–672.PubMedGoogle Scholar
  52. Pfohl B, Sherman B, Schlechte J, Stone R: Pituitary—adrenal axis rhythm distur- bances in psychiatric depression. Arch Gen Psychiat 1985; 42: 897–903.PubMedCrossRefGoogle Scholar
  53. Reul JMHM, de Kloet ER: Two receptor systems for corticosterone in rat brain: Microdistribution and differential occupation. Endocrinology 1985; 117: 2505–2512.PubMedCrossRefGoogle Scholar
  54. Reus VI, Joseph MS, Dallman MF: ACTH levels after the dexamethasone suppression test in depression. N Engl J Med 1982; 306: 238–239.PubMedGoogle Scholar
  55. Risch SC: Beta-endorphin hypersecretion in depression: Possible cholinergic mechanisms. Biol Psychiat 1982; 17: 1071–1079.PubMedGoogle Scholar
  56. Rubin RT, Poland RE, Lesser IM, Martin DJ, Blodgett ALN, Winston RA: Neuroendocrine aspects of primary endogenous depression III. Cortisol secretion in relation to diagnosis and symptom patterns. Psychol Med 1987; 17: 609–619.PubMedCrossRefGoogle Scholar
  57. Sachar EO, Hellman L, Roffward H, Halpern F, Fukushima D, Gallagher D: Disrupted 24-hour patterns of cortisol secretion in psychotic depression. Arch Gen Psychiat 1973; 28: 19.PubMedCrossRefGoogle Scholar
  58. Sapolsky RM: Glucocorticoid toxicity in the hippocampus: Temporal aspects ofGoogle Scholar
  59. synergy with kainic acid. Neuroendocrinology 1986; 43: 440–444.CrossRefGoogle Scholar
  60. Sapolsky R, Krey L, McEwen B: The adrenocortical stress-response in the aged male rat: Impairment of recovery from stress. Exp Gerontol 1983a; 18: 55–64.PubMedCrossRefGoogle Scholar
  61. Sapolsky RM, Krey LC, McEwen BS: Corticosterone receptors decline in a sitespecific manner in the aged rat brain. Brain Res 1983b; 289: 235–240.PubMedCrossRefGoogle Scholar
  62. Sapolsky RM, Krey LC, McEwen BS: Glucocorticoid-sensitive hippocampal neurons are involved in terminating the adrenocortical stress response. Proc Natl Acad Sci 1984; 81: 6174–6177.PubMedCrossRefGoogle Scholar
  63. Schiesser MA, Winokur G, Sherman BM: Hypothalamic-pituitary-adrenal axis activity in depressive illness: Its relationship to classification. Arch Gen Psychiat 1980; 37: 737–743.CrossRefGoogle Scholar
  64. Schweitzer I, Maguire KP, Gee AH, Tiller JWG, Biddle N, and Davies B: Prediction of outcome in depressed patients by weekly monitoring with the dexamethasone suppression test. Brit J Psychiat 1987; 151: 780–784.PubMedCrossRefGoogle Scholar
  65. Selye H: A syndrome produced by diverse noxious agents. Nature 1936; 138: 32.CrossRefGoogle Scholar
  66. Stokes PE, Pick GR, Stoll PM et al.: Pituitary-adrenal function in depressed patients: resistance to dexamethasone suppression. J Psychiat Res 1975; 12: 271–281.CrossRefGoogle Scholar
  67. Stokes PE, Sikes CR, Stoll PM: Adrenocortical responsiveness in major depression. Annual Meeting of Society of Biological Psychiatry. Program Abstracts No. 103. Montreal, Quebec, 1988.Google Scholar
  68. Tiongco DD, Hariharan M, Haskett RF, Greden JF: Age effects on HPA regulation and dexamethasone plasma levels in normal subjects. In Annual Meeting of the Society of Biological Psychiatry, Program Abstracts (pp. 195 ). Washington, DC, 1986.Google Scholar
  69. Vale W, Spiess J, Rivier C, Rivier J: Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and 0-endorphin. Science 1981; 213: 1394–1397.PubMedCrossRefGoogle Scholar
  70. Young EA, Akil H: Corticotropin-releasing factor stimulation of adrenocorticotropin and 0-endorphin release: Effects of acute and chronic stress. Endocrin 1985; 117: 23–30.CrossRefGoogle Scholar
  71. Young EA, Watson JS, Kotun J, Haskett RF, Greden JF, Grunhaus L, Murphy-Weinberg V, Vale W, Rivier J, Akil H: ß-LPH/ß-Endorphin response to low-dose oCRH in endogenous depression: Preliminary studies. Arch Gen Psychiat 1990; 47: 449–457.PubMedCrossRefGoogle Scholar
  72. Young EA, Haskett RF, Murphy-Weinberg V, Watson SJ, Akil H: Loss of glucocorticoid fast feedback in depression. Arch Gen Psychiat 1991; 48: 693–699.PubMedCrossRefGoogle Scholar
  73. Young EA, Kotun J, Haskett RF, Grunhaus L, Greden JF, Watson SJ, and Akil H: Dissociation between pituitary and adrenal suppression to dexamethasone in depression. Arch Gen Psychiat 1992 (in press).Google Scholar
  74. Zis K, Zis A: Increased adrenal weight in victims of violent suicide. Am J Psychiat 1987; 144: 1214–1216.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1993

Authors and Affiliations

  • Roger F. Haskett
    • 1
  1. 1.Department of PsychiatryUniversity of Pittsburgh School of Medicine, Western Psychiatric Institute and ClinicPittsburghUSA

Personalised recommendations